IMUGENE CHART. TA only, page-31049

First 31049 Last

Share
Profile

Follow
dory

6,055 Posts.

982

05/04/24

14:12

Post #: 73208138
Share

Originally posted by Zior ↑

How does one see what the market is doing when it appears to be stagnant? The very simple answer is moving averages. While things appear to be dormant here at Imugene, don't be fooled by the thought that 'nothing is happening'.

For those who think 'one can't possibly have a clue what is going to happen' , save yourself some time and skip this post - it's not for you. The truth is that comment is highly accurate in your own case.

For those who are interested in what the high probability outcomes are for the current situation, take a look below. This is just a brief post because not a great deal has changed, so my last analysis update (and all prior comments: see bottom of that post) is still very much on point.

Weekly
We are in the process of bouncing off our bottom support - the yellow e21. Perfect position to be in for a news release (unless it's negative which is very unlikely at this point) expect to see the price move up from this level as this pull-back is quite tired now. A nice little close this afternoon would confirm that doji last week as a reversal.

Daily
Those two MA's are annoyingly close and slow, the blue 100 and the red 200. Once they cross then we should be on our way - this is the main technical event on this chart. The cross over will be the unshackeling that will get us to 0.22 and beyond. 15c is highly probable from here regardless of news or not. Once that 22c target became official, that interim target of 15c was locked in. That's why I've had the confidence of a break up since Nov and have never wavered from to no, despite the criticism of people who should know better. At present, while we wait for that crossover we are looking at a nice little bullish divergence which should help push the price along in coming sessions.

I'm tipping a good week next week based on technicals, with positive news it could be a great one!

Expand

morning

there is nothing bullish about imu's chart - nothing.

not even the short stories

regards

IMU Price at posting: 10.3¢ Sentiment: Hold Disclosure: Not Held
6 Upvote

1 Great analysis

Reply

Top Stories

MXR

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 3,781 more messages in this thread...

First 31049 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.0¢		Change -0.001(1.00%)		Mkt cap ! $364.4M

Open	High	Low	Value	Volume
5.0¢	5.0¢	4.8¢	$317.9K	6.475M

Buyers (Bids)

No.	Vol.	Price($)
24	1290901	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.0¢	5321020	34

View Market Depth

No.	Vol.	Price($)
20	1228758	0.049
42	4255925	0.048
48	5253216	0.047
58	4326744	0.046
60	8370830	0.045

Price($)	Vol.	No.
0.050	5670891	34
0.051	6104818	13
0.052	1499129	10
0.053	1894821	13
0.054	1735517	8

Last trade - 12.29pm 02/10/2024 (20 minute delay)

IMU (ASX) Chart

IMUGENE CHART. TA only, page-31049

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

IMUGENE CHART. TA only, page-31049

Top Stories

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News